Medindia

X

Ranbaxy Subsidiary in Rs 605 Crore Deal to Supply Anti-HIV Drugs in SA

by Kathy Jones on  December 20, 2010 at 8:58 PM Corporate News   - G J E 4
India's largest drug maker, Ranbaxy Laboratories has announced that its South African joint venture, Sonke Pharmaceuticals has won a mega deal worth Rs 605 crore to supply anti-HIV drugs in the country.
 Ranbaxy Subsidiary in Rs 605 Crore Deal to Supply Anti-HIV Drugs in SA
Ranbaxy Subsidiary in Rs 605 Crore Deal to Supply Anti-HIV Drugs in SA
Advertisement

Sonke Pharmaceuticals is a joint venture started by Ranbaxy Ltd and Community Investment Holdings (CIH) with Ranbaxy holding a majority 70 percent stake in the company. Ranbaxy revealed that the order was part of a bigger anti-retroviral (ARV) tender floated by the South African government and amounts to around 913.5 million rand.

Advertisement
Ranbaxy went on to confirm that some of the drugs will be manufactured locally while the remaining will be manufactured at Ranbaxy's facilities in India. The Managing Director of the company, Arun Sawhney said that Ranbaxy was pleased to be awarded with the order and is committed to bringing in quality medicines into the country.

"We are humbled to be given this responsibility to produce, supply and distribute affordable ARVs in South Africa. As a socially responsible global pharmaceutical company, we are committed to the cause of alleviating the suffering due to HIV AIDS and to bring high quality medication to those who need it the most", he said.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All